Age
Item
men or women between 18 and 80 years.
boolean
C0001779 (UMLS CUI [1])
Parkinson Disease
Item
patient has idiopathic parkinson's disease according to brain bank criteria. -
boolean
C0030567 (UMLS CUI [1])
Bibliographic Reference
Item
reference hughes a j, daniel s e, kilford l, lees a j, accuracy of clinical -
boolean
C1514811 (UMLS CUI [1])
Bibliographic Reference
Item
diagnosis of idiopathic parkinson's disease; a clinical pathological study of 100 cases, jnnp 1992, 55(3): 181 - 184
boolean
C1514811 (UMLS CUI [1])
Antiparkinson Agents Dose Stable | Antiparkinson Agents unchanged
Item
patient is on stable doses of anti-parkinson's disease medication, which are not expected to change during the study period.
boolean
C0003405 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0003405 (UMLS CUI [2,1])
C0442739 (UMLS CUI [2,2])
Levodopa | Dopamine Agonists
Item
patient is taking levodopa and/or dopamine agonist treatment.
boolean
C0023570 (UMLS CUI [1])
C0178601 (UMLS CUI [2])
Pharmaceutical Preparations Intake Using Electronic monitor System
Item
patient (assisted by a carer where appropriate) is able to take their medication using the mems (electronic monitoring) containers.
boolean
C0013227 (UMLS CUI [1,1])
C1512806 (UMLS CUI [1,2])
C1524063 (UMLS CUI [1,3])
C0336646 (UMLS CUI [1,4])
C0449913 (UMLS CUI [1,5])
Dosette Use of | Pharmaceutical Preparations Intake Using Electronic monitor System
Item
patients using a dosette box or similar device for their medication are willing to use the mems containers for their pd medication
boolean
C1553470 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C1512806 (UMLS CUI [2,2])
C1524063 (UMLS CUI [2,3])
C0336646 (UMLS CUI [2,4])
C0449913 (UMLS CUI [2,5])
Patient care | Symptom control | Study Subject Participation Status | Pharmaceutical Preparations Intake Using Electronic monitor System
Item
the investigator judges that the patient's care and symptom control will not be adversely affected by entering the study and using the mems device.
boolean
C0017313 (UMLS CUI [1])
C1274136 (UMLS CUI [2])
C2348568 (UMLS CUI [3])
C0013227 (UMLS CUI [4,1])
C1512806 (UMLS CUI [4,2])
C1524063 (UMLS CUI [4,3])
C0336646 (UMLS CUI [4,4])
C0449913 (UMLS CUI [4,5])
Therapeutic procedure Intermittent Parkinson Disease | Domperidone
Item
patient is taking anti-parkinson's disease therapy intermittently or on "as required" basis (such as rescue therapy for off periods). intermittent domperidone is allowed.
boolean
C0087111 (UMLS CUI [1,1])
C0205267 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,3])
C0013015 (UMLS CUI [2])
Comorbidity Severe | Heart Disease Severe | Liver disease Severe | Kidney Disease Severe | Malignant Neoplasms | Parkinson Disease | Life Expectancy | Level of Care Patient need for
Item
severe co-morbid condition such as severe heart, liver, or kidney disease or cancer diagnosis where the co-morbid condition is of greater health significance than the parkinson's disease in terms of life expectancy and levels of care required.
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0018799 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0023895 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0022658 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0006826 (UMLS CUI [5])
C0030567 (UMLS CUI [6])
C0023671 (UMLS CUI [7])
C1547668 (UMLS CUI [8,1])
C0686904 (UMLS CUI [8,2])
Hospital admission Expected | Elective Surgical Procedures
Item
patient is expected to undergo hospital admission during the study period (such as elective surgery).
boolean
C0184666 (UMLS CUI [1,1])
C1517001 (UMLS CUI [1,2])
C0206058 (UMLS CUI [2])
Pharmacotherapy Investigational | Combined Modality Therapy | Dopamine Agonists Different Quantity | Dopamine Agonists High dose
Item
patient is on non standard drug treatment / combination therapy. this would include e.g. a combination of 2 different oral dopamine agonists, doses of dopamine agonist taken at higher than recommended for routine practice.
boolean
C0013216 (UMLS CUI [1,1])
C1517586 (UMLS CUI [1,2])
C0009429 (UMLS CUI [2])
C0178601 (UMLS CUI [3,1])
C1705242 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0178601 (UMLS CUI [4,1])
C0444956 (UMLS CUI [4,2])
Antiparkinson Agents new therapy
Item
new antiparkinson treatment is being introduced at the time of recruitment or during the one month monitoring period.
boolean
C0003405 (UMLS CUI [1,1])
C3242274 (UMLS CUI [1,2])
Adjuvant therapy | Selegiline | Amantadine | Anticholinergic Agents
Item
patient is taking only adjunct therapy (eg. selegiline, amantadine, anticholinergic therapy).
boolean
C0677850 (UMLS CUI [1])
C0036579 (UMLS CUI [2])
C0002403 (UMLS CUI [3])
C0242896 (UMLS CUI [4])
Study Subject Participation Status
Item
patient is taking part in a clinical trial.
boolean
C2348568 (UMLS CUI [1])